<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02660593</url>
  </required_header>
  <id_info>
    <org_study_id>SanGrow Decoction for diabetes</org_study_id>
    <nct_id>NCT02660593</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety ofSanGrow Decoction for Patients With Diabetes</brief_title>
  <official_title>SanGrow Decoction in Patients With Diabetes- Single Center, Open, and Non-randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shidaihuajing Institute for Diabetic Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shidaihuajing Institute for Diabetic Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MedlinePlus related topics: Blood Sugar

      Primary Outcome Measures:

        -  Fast glucose and HbA1c change between the baseline and end of study [ Time Frame: From
           baseline to 30 and 100 days]

        -  [ Designated as safety issue: No ]

        -  Successful rate of blood glucose control (the proportion of patients with HbA1c &lt;7%) [
           Time Frame: From baseline to 30 days and 100 days] [ Designated as safety issue: No ]

      Secondary Outcome Measures:

      â€¢ To evaluate the change of quality of life in the 1 months by the health questionnaire SF-36
      [ Time Frame: From baseline to month 1 ] [ Designated as safety issue: No ]
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is aimed to evaluate the safety and efficacy of Sangrow Decotion, diet and
      exercise for the treatment of type 2 diabetes. Previous study has shown that this therapeutic
      regimen is safe and effective.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Sugar level</measure>
    <time_frame>From baseline to 30 and 90 days</time_frame>
    <description>Fast glucose change between the baseline and end of study</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>SanGrow</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be given SanGrow Decoction 150 ml per day for 3 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>SanGrow Decoction</intervention_name>
    <description>SanGrow Decoction is perpared according to the principle of Chinese medicine to treat thirsty and maransis.</description>
    <arm_group_label>SanGrow</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type II diabetes mellitus patients who have received medical treatment for more than 3
             months

          -  Patients willing to sign written informed consent form

        Exclusion Criteria:

          -  Patients unable or unwilling to comply with the requirements of the protocol

          -  Females who are pregnant or nursing or females of childbearing potential who are
             unwilling to maintain contraceptive therapy for the duration of the study

          -  Life expectancy &lt; 6 months due to concomitant illnesses.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shizhan CHi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Shidaihuajing Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shizhan Chi, PhD</last_name>
    <phone>86-10-53109996</phone>
    <phone_ext>8088</phone_ext>
    <email>chishizhan@lawyee.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jiuhua Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chi Shizhan, Master</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xuanwu Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chi Shizhan, Master</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2016</study_first_submitted>
  <study_first_submitted_qc>January 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2016</study_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Chinese medicine</keyword>
  <keyword>exercise</keyword>
  <keyword>diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

